{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-028873","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2022-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.749662+00:00","generated_at":"2026-06-23T02:45:19.456322+00:00","sec_items":["1.01","3.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TenX Keane Acquisition closes $66M IPO; $67.3M placed in trust for business combination","bullets":["IPO of 6,600,000 units at $10/unit (including 600,000 over-allotment units) for gross proceeds of $66,000,000.","Private placement of 394,000 placement units to sponsor at $10/unit, raising additional $3,940,000.","Total $67,320,000 deposited into trust account for the benefit of public shareholders.","Units trade on Nasdaq as TENKU; shares as TENK; rights as TENKR.","Maxim Group LLC acted as sole book-running manager; IPO closed October 18, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-028873","json":"https://secwatch.observer/filing/0001493152-22-028873.json","markdown":"https://secwatch.observer/filing/0001493152-22-028873.md","text":"https://secwatch.observer/filing/0001493152-22-028873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000149315222028873/0001493152-22-028873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000149315222028873/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:45:19.456322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}